EDSA
Edesa Biotech, Inc. Common Shares
stockNASDAQ
Market OpenNov 9, 2026 10:46:11 AM EST
2.99USD+39.720%(+0.85)59,718,533
Pre-marketNov 9, 2026 9:29:59 AM EST
3.51USD+64.019%(+1.37)
Loading…
Loading…
29.41M
Healthcare
Biotechnology
HQ
Markham, ON, Canada
Previous Close
$2.17
Beta
-0.61
52-Week High
$20.32 2026-05-01
52-Week Low
$0.72 2026-02-20
SMA 50
$3.54
SMA 200
$5.68
Avg. Vol 10D
44,916
Avg. Vol 30D
44,852
Avg. Vol 90D
58,160
Relative Vol
715.35
9.64M
7.68M
79.67%
161,309
2.10%
3.51
37%/63%
16.91%
15.09%
58.1900%
2,147
1,286
5,022
Dec 11, 2026 (32d)
Oct 11, 2023 · 1-for-7 (reverse)
-14.1M
-122.93
Nov 9, 2026
Edesa Biotech licenses ARDS drug to Kyorin for Japan market · 
Investing.com
Nov 4, 2026
Edesa Biotech to Present at Guggenheim Healthcare Innovation Conference · 
GlobeNewswire Inc.
Oct 29, 2026
EDSA Profile
founded in 2015, edesa biotech brings innovative new treatments for dermatological and anorectal diseases. late-stage prescription drugs developed by edesa biotech aim to help patients who experience limited treatment options. edesa biotech's focus on dermatology is led by an experienced team that have licensed global rights to clinical stage assets for dermatology and anorectal indications.
EDSA Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 2.44 | 2026-11-02 | +25.00% | -0.401 |
| 1M | 3.51 | 2026-10-09 | -13.10% | 0.351 |
| 3M | 5.24 | 2026-08-10 | -41.79% | 0.481 |
| 6M | 16.30 | 2026-05-08 | -81.29% | 0.415 |
| 1Y | 1.73 | 2025-11-10 | +76.31% | -0.614 |
| 2Y | 2.42 | 2024-11-08 | +26.04% | — |
| 5Y | 52.01 | 2021-11-09 | -94.14% | 0.800 |
EDSA Stock Summary
Edesa Biotech, Inc. Common Shares (NASDAQ:EDSA) stock price today is $3.05, and today's volume is 32,084,916. EDSA is up 42.528% today. The 30 day average volume is 44,852. EDSA market cap is $29.41M with 9.64M shares outstanding.